We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Warning Letter to Minnesota OTC Manufacturer
FDA Issues Warning Letter to Minnesota OTC Manufacturer
December 5, 2005
The FDA has issued a warning letter to Minnesota-based OTC drugmaker Diversified Manufacturing, accusing the company of violating current good manufacturing practices (cGMPs).